Spotlight Growth
No Result
View All Result
Saturday, February 4, 2023
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
No Result
View All Result
No Result
View All Result
Home Cannabis

Elev8 Brands, Inc. (OTC Pink: VATE) Climbed 32.29% After Retiring 200 Million Shares

by admin
March 13, 2018
in Cannabis
0
CBD Oil Elev8 Brands Hemp Sales News

CBD Oil Elev8 Brands Hemp Sales News

Elev8 Brands, Inc. (OTC Pink: VATE) is a holding company active across the industrial hemp and CBD industries. Products offered include hemp-infused coffee, tea, e-juices, lotions, tinctures, and more. Shares of the CBD company rallied 32.29% during trading on Tuesday, March 13, 2018. Over the past month, Elev8 Brands, Inc. has seen average daily volume of 3.68 million shares. However, volume of 16.68 million shares or dollar volume of $772,284, exchanged hands on the day.

Shares of Elev8 Brands, Inc. jumped today after the company announced that it has retired 200 million shares of the common stock and now has a current outstanding share count of 363.23 million shares. Management also announced the company has unveiled three new hemp coffees and a 300mg Zoe CBD Tincture, which are now available. Here is the full press release detailing of the update:

Elev8 Brands, Inc. Press Release:

ORLANDO, Fla., March 13, 2018 (GLOBE NEWSWIRE) — Via OTC PR Wire — Elev8 Brands, Inc. (OTC Pink:VATE), a holding company focused on the commercial development of hemp and CBD-based products including hemp coffee, tea, E-juices, CBD Lotions and CBD Tinctures that target the health and wellness markets, is pleased to announce the retirement of over Two Hundred Million (200,000,000) shares of common stock by the Company’s Management Team.

The Company has been working diligently to maintain a solid share structure to help increase shareholder value. Elev8’s management team was able to negotiate the retirement of over Two Hundred Million (200,000,000) shares of common stock. The current Issued and Outstanding as of March 13th, 2018 is 363,232,031.

CEO Ryan Medico stated, “Coming out of February, being our best month in sales to date, we are extremely positive in the direction the company is heading. I will personally be updating everyone on the exciting progress of the company via CEO Letters on the OTC Markets within the week.”

The Company recently announced three new Elev8 Hemp Coffees and 300mg Zoe CBD Tinctures that are now available for sale. Elev8 Brands is pleased to bring more variations from its popular Hemp Coffee line. The Company will now be offering its coffee in a Dark Roast, Espresso, and Chocolate Raspberry Truffle. The Company’s Hemp Coffee line has been consistently selling out of brick and mortar stores as well as online. Due to the high demand for Elev8’s Hemp Coffee products, the Company’s management team decided to increase the number of blends offered to allow Elev8 Brands to further grow its market share.

About Elev8 Brands, Inc.:
Elev8 Brands, Inc. specializes in the development and marketing of products for the fitness and wellness markets. The company is founded based on creating high-quality, sustainable, products for health-conscious consumers.

About Elev8 Hemp LLC:
Elev8 Hemp LLC is a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on the development and marketing of hemp-based food, beverage, and health care products including hemp coffee and hemp tea.

About 02 Breathe LLC:
02 Breathe is a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on their oxygen bar while bringing in an array of CBD products. O2 Breathe carries CBD tinctures, CBD vape, CBD lotions and massage products. 02 Breathe is currently looking to offer CBD at their oxygen bar.

About Zoe CBD LLC:
Zoe CBD is a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on the development and marketing of CBD-based products such as CBD Tinctures, CBD E-Juice, CBD Lotion and CBD Salve.

Please visit, http://www.zoecbd.com for more information

www.facebook.com/elev8hemp
www.instagram.com/elev8hemp
www.twitter.com/elev8hemp
www.02breathe.com

Safe Harbor Statement:
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words “may,” “will,” “should,” “plans,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company’s control.

Tags: cannabiscommon stockemerging growthinvestmentmarijuana stocksmedicalmedical cannabismedical marijuanaMergermicrocap stockspharmaceuticalspublic companysalessmall cap companiessmall cap stockssmall capsSpotlight GrowthSpotlight Growth Stockstreatment
  • Trending
  • Comments
  • Latest
Asure Software NASDAQ ASUR Human Capital Management HCM Industry Spotlight Growth

Asure Software (NASDAQ: ASUR) is Expanding to Meet the Rising Demand for Human Capital Management Software

September 27, 2022
OLB Group NASDAQ OLB Cuentas NASDAQ CUEN Partnership Fintech Spotlight Growth

OLB Group (NASDAQ: OLB) and Cuentas (NASDAQ: CUEN) Team Up to Bring Fintech Solutions to Over 32,000 Bodegas Across the United States

October 6, 2022
Siyata Mobile NASDAQ SYTA SYTAW SD7 VK7 Purchase Orders Spotlight Growth

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

December 14, 2021
Telcoin TEL Crypto Spotlight Growth

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

June 15, 2021
Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

0
Safe-T SFET NASDAQ UN Presentation

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

0
Safe-T Group SFET Q4 FY 2020 Financial Results

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

0
Safe-T Group NASDAQ SFET FY 2020 Prelim

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

0
Can the AI Boom Rebuild Investor Enthusiasm for Upstart Holdings NASDAQ UPST Spotlight Growth

Can the AI Boom Rebuild Investor Enthusiasm for Upstart Holdings (NASDAQ: UPST)?

February 3, 2023
Nerdy NYSE NRDY New AI Products Lesson Plan Creator Chat Tutor Spotlight Growth

Nerdy (NYSE: NRDY) Unveils New AI Tools for Lesson Plan Creation and Chat Tutoring

February 3, 2023
Elys Game Technology Corp NASDAQ ELYS Completes Acquisition of Engage IT Services Spotlight Growth

Elys Game Technology Corp (NASDAQ: ELYS) Completes Acquisition of Engage IT Services, a Software Engineering and IT Development Company

February 2, 2023
Tenax Therapeutics NASDAQ TENX US Patent Levosimendan PH-HFpEF Spotlight Growth

Tenax Therapeutics (NASDAQ: TENX) Granted U.S. Patent for IV Levosimendan for Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

February 2, 2023
ADVERTISEMENT

Recent News

Can the AI Boom Rebuild Investor Enthusiasm for Upstart Holdings NASDAQ UPST Spotlight Growth

Can the AI Boom Rebuild Investor Enthusiasm for Upstart Holdings (NASDAQ: UPST)?

February 3, 2023
Nerdy NYSE NRDY New AI Products Lesson Plan Creator Chat Tutor Spotlight Growth

Nerdy (NYSE: NRDY) Unveils New AI Tools for Lesson Plan Creation and Chat Tutoring

February 3, 2023

Categories

  • Bio/Med/Pharma
  • Cannabis
  • Commodities
  • Consumer Goods
  • Crowdfunding
  • Crypto Cheat Sheets
  • Cryptocurrency
  • Earnings
  • Education
  • Entertainment
  • Financials
  • Market News
  • Opinion
  • Politics
  • Real Estate
  • Split Watch
  • Sponsored
  • Store
  • Technology
  • Uncategorized
  • Venture Capital/Private Equity (VC/PE)

Site Navigation

  • Disclosures
  • Terms Of Service
  • Privacy Policy
  • Contact Us

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

No Result
View All Result
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.

Enter your email address

Thanks, I’m not interested